Viewing Study NCT02206503


Ignite Creation Date: 2025-12-24 @ 7:21 PM
Ignite Modification Date: 2026-01-02 @ 10:05 AM
Study NCT ID: NCT02206503
Status: COMPLETED
Last Update Posted: 2018-08-02
First Post: 2014-02-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)
Sponsor: Fondazione EMN Italy Onlus
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module